Skip to main content
. 2017 May 17;12(5):e0177752. doi: 10.1371/journal.pone.0177752

Table 1. Outcomes of the QuantiFERON®-TB Gold In-Tube test versus the tuberculin skin test among 856 U.S. Navy recruits who had blood collected and skin test placed.

QFT-GIT results
TST Results Recruit Category a Negative Positive Indeterminate Incomplete All
< 5 mm All 726 9 5 45 785
Low Risk 489 5 3 38 535
Increased Risk 237 4 2 7 250
≥ 5 and < 10 mm All 10 0 0 0 10
Low Risk 7 0 0 0 7
Increased Risk 3 0 0 0 3
≥ 10 and < 15 mm All 19 0 0 0 19
Low Risk 4 0 0 0 4
Increased Risk 15 0 0 0 15
≥ 15 mm All 18 5 0 1 24
Low Risk 4 1 0 0 5
Increased Risk 14 4 0 1 19
Incomplete All 18 0 0 0 18
Low Risk 12 0 0 0 12
Increased Risk 6 0 0 0 6
All All 791 14 5 46 856
Low Risk 516 6 3 38 563
Increased Risk 275 8 2 8 293

QFT-GIT = QuantiFERON®-TB Gold In-Tube test; TST = tuberculin skin test.

a Navy recruits were categorized as having an “increased risk” for M. tuberculosis infection if they did not meet the “tuberculosis-suspect” criteria, but reported contact with someone with TB, birth (or residence >1 month) in a country where estimated TB prevalence exceeded 20 cases per 100,000 population, or having resided, worked, or volunteered >1 month in a homeless shelter, jail, prison, drug rehabilitation unit, hospital, or nursing home; or as having a “low risk” for M. tuberculosis infection if they were neither suspects nor at increased risk.